Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol

Published:2009-09-03 Issue:3 Volume:54 Page:355-360
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Hempel Georg,Relling Mary V.,de Rossi Giulio,Stary Jan,De Lorenzo Paola,Valsecchi Maria Grazia,Barisone Elena,Boos Joachim,Pieters Rob

Funder

German Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22266/fullpdf

Reference19 articles.

1. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: A systematic review;Kremer;Ann Oncol,2002

2. Anthracycline dose in childhood acute lymphoblastic leukemia: Issues of early survival versus late cardiotoxicity;Sorensen;J Clin Oncol,1997

3. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer;Lipshultz;N Engl J Med,1995

4. Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis;Hempel;J Chromatogr B Biomed Sci Appl,2001

5. Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: How much do we really know?;Cole;Pediatr Blood Cancer,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and optimization of therapies for acute lymphoblastic leukemia in infants;International Journal of Hematology;2022-11-28

2. Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial;Pharmaceutics;2022-04-05

3. Neonatal Leukemia;Clinics in Perinatology;2021-03

4. How I treat infant leukemia;Blood;2019-01-17

5. Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06;Leukemia & Lymphoma;2019-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3